Cobo Marc
Cobo Marc, PAO, reported a transaction classified as withholding at BridgeBio Oncology Therapeutics, Inc. involving 203.000000 shares for an estimated $1120.56. Reported holdings after the transaction were 14141.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Sep 10, 2026
- Filing date
- Sep 14, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
BBOT price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- withholding Code F
- Identifier
- 0001193125-26-390624 Common Stock
- Transaction date
- Sep 10, 2026 Filed Sep 14, 2026, 08:24 PM · 4d delay
- Shares
- 203 sh $5.52 per share
- Estimated value
- -$1.12k Computed from shares × price
- Holdings after
- 14,141 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-16 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - tax_withholding-22 points
transaction_code = F
Tax withholding on vesting shares is mechanical.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Principal Accounting Officer
- F1
Represents a grant of restricted stock units ("RSUs"), each representing a contingent right to receive one share of the Issuer's Common Stock. The RSUs vest in 16 equal quarterly installments over a p…
- F2
Represents the number of shares of the Issuer's Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of RSUs.
- F3
1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of April 21, 2026, subject to the Reporting Person's con…
0 other transactions
0 recent txs